CLINICAL_TRIALS
trial_result
· 2013-04-10
Clinical Trial Update: Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women [Phase 3]
Summary
Pfizer completed a Phase 3 trial evaluating bazedoxifene acetate for osteoporosis in postmenopausal women; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2013-04-10